MetLife Investment Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $300K | Buy |
154,029
+64,694
| +72% | +$126K | ﹤0.01% | 1959 |
|
|
2025
Q1 | $157K | Sell |
89,335
-14,312
| -14% | -$25.2K | ﹤0.01% | 2318 |
|
|
2024
Q4 | $276K | Buy |
103,647
+12,596
| +14% | +$33.5K | ﹤0.01% | 2128 |
|
|
2024
Q3 | $209K | Sell |
91,051
-14,627
| -14% | -$33.5K | ﹤0.01% | 2266 |
|
|
2024
Q2 | $309K | Buy |
105,678
+20,287
| +24% | +$59.2K | ﹤0.01% | 1986 |
|
|
2024
Q1 | $311K | Buy |
85,391
+6,103
| +8% | +$22.2K | ﹤0.01% | 1942 |
|
|
2023
Q4 | $120K | Hold |
79,288
| – | – | ﹤0.01% | 2516 |
|
|
2023
Q3 | $106K | Hold |
79,288
| – | – | ﹤0.01% | 2549 |
|
|
2023
Q2 | $143K | Buy |
79,288
+12,996
| +20% | +$23.4K | ﹤0.01% | 2480 |
|
|
2023
Q1 | $110K | Buy |
66,292
+23,504
| +55% | +$39K | ﹤0.01% | 2506 |
|
|
2022
Q4 | $82.2K | Sell |
42,788
-22,051
| -34% | -$42.3K | ﹤0.01% | 2666 |
|
|
2022
Q3 | $145K | Hold |
64,839
| – | – | ﹤0.01% | 2479 |
|
|
2022
Q2 | $210K | Sell |
64,839
-24,836
| -28% | -$80.5K | ﹤0.01% | 2291 |
|
|
2022
Q1 | $472K | Buy |
89,675
+31,975
| +55% | +$168K | ﹤0.01% | 1805 |
|
|
2021
Q4 | $490K | Buy |
57,700
+32,149
| +126% | +$273K | ﹤0.01% | 1515 |
|
|
2021
Q3 | $254K | Buy |
25,551
+8,557
| +50% | +$85.1K | ﹤0.01% | 1937 |
|
|
2021
Q2 | $158K | Buy |
+16,994
| New | +$158K | ﹤0.01% | 2298 |
|